Tag Archives: Next Generation Sequencing

Highlights from the Leerink Swann Healthcare Conference

By Ben Comer | Published: March 13, 2012

Over a hundred public companies, dozens of clinicians, and several regulators participated in investment firm Leerink Swann’s 2012 Healthcare Conference in mid-February. Press was barred from the event, but John Sullivan, Leerink’s director of research, gives PharmExec a few of the take-aways.

Posted in Biotech, Events, FDA, Gene therapy, Strategy, Technology, leadership | Also tagged CDER, companion diagnostics, conference, DNA, FDA, genetics, Janet Woodcock, Leerink Swann | Leave a comment